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Plasmids expressing partial adenovirus early region 1A (ElA) coding sequences were tested for activities
which facilitate in vitro establishment (immortalization) of primary baby rat kidney cells and which enable the
T24 Harvey ras-related oncogene and the polyomavirus middle T antigen (pmt) gene to transform primary baby
rat kidney cells. ElA cDNAs expressing the 289- and 243-amino acid proteins expressed both ElA transforming
functions. Mutant hrA, which encodes a 140-amino acid protein derived from the amino-terminal domain
shared by the 289- and 243-amino acid proteins, enabled ras (but not pmt) to transform and facilitated in vitro
establishment to a low, but detectable, extent. These studies suggest that ElA functions which collaborate with
ras oncogenes and those which facilitate establishment are linked. Furthermore, ElA transforming functions
are not associated with activities of the 289-amino acid ElA proteins required for efficient transcriptional
activation of viral early region promoters.
The early region 1A (E1A) transcription unit of human
adenovirus encodes products important in oncogenic trans-
formation. In particular, ElA expresses activities which
extend the growth potential of cultured primary cells, result-
ing in cells capable of growing indefinitely in vitro as
established cell lines (24). In addition, ElA can collaborate
with both viral genes and cellular oncogenes to transform
cultured primary cells (45).
Two lines of evidence suggest that ElA establishment
functions are linked to the ability to collaborate with other
oncogenes in primary cell transformation. (i) Neither the
gene encoding the polyomavirus middle T antigen (pmt) nor
the Harvey ras-related oncogene isolated from T24 bladder
carcinoma cells (T24 Ha-ras) is individually able to trans-
form certain primary rodent cells after DNA-mediated gene
transfer (28, 33, 39, 42, 45), whereas these genes readily
transform cells from a variety of established lines (7, 17, 28,
39, 42, 55). (ii) Genes other than ElA, which collaborate
with the T24 Ha-ras oncogene in primary cell transforma-
tion, namely, polyomavirus large T antigen (plt), avian
myelocytomatosis virus, myc, and p53 (13, 33, 40), also
facilitate the establishment of primary cells (28, 43, 46).
The physiological basis for ElA-induced establishment of
primary rodent cells is presently unknown; moreover, the
role of individual ElA proteins has not been determined.
Coding sequences for three related proteins are generated by
differential splicing of adenovirus ElA transcripts during
lytic infection. The 289- and 243-amino acid proteins are
encoded by 13S and 12S mRNAs, respectively. Since the
splicing process maintains the reading frames of both
mRNAs (41), the 289- and 243-amino acid proteins differ
only by 46 internal amino acids. The third ElA transcript, a
9S mRNA, is most abundant late during lytic infection and
has not been detected in adenovirus-transformed cells.
Several biological activities for the ElA proteins have
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been described, but it is not known whether any of these are
relevant to transformation. In particular, adenovirus genes
are coordinately regulated during lytic infection, and ElA is
required for efficient transcription of viral early region genes
(4, 29). ElA proteins also influence the transcription of a
number of cellular genes, both resident within the genome
and carried on transfected plasmids (1, 5, 21, 30, 34, 47, 53,
54, 56). Finally, ElA expression is required for efficient
adenovirus infection of quiescent cells (37), stimulation of
cellular DNA synthesis (3, 52), and cell cycle progression
(3).
It is not known whether one or several biochemical
activities are responsible for these biological effects. How-
ever, one might speculate that transcriptional effects, loss of
cell cycle controls, chromosome abnormalities, collabora-
tion with oncogenes, and establishment of primary cells
could all be manifestations of the same biochemical activity.
In the present study, plasmids capable of expressing
limited portions of ElA coding sequences were tested for
their ability to collaborate with transforming genes in pri-
mary cell transformation and to promote the establishment
of primary cells in vitro. Analysis of ElA transforming
functions by cotransfection with viral and cellular transform-
ing genes offers several advantages over analysis of viral
transformation. In particular, the transforming abilities of
mutant ElA transcription units can be assessed in the
absence of either viral cytotoxicity or transcriptional effects
such as the autoregulation of ElA or the activation of E1B.
The experiments reported here addressed related goals.
We localized ElA functions important in primary cell trans-
formation and examined the linkage between ElA functions
which facilitate establishment of cultured primary cells and
those which collaborate with transforming genes in primary
cell transformation. Since the biochemical activities of ElA
proteins are presently unknown, close associations among
two or more of the biological effects induced by ElA will
help clarify whether these result from a single biochemical
activity.
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FIG. 1. Construction of ElA 13S and 12S cDNA expression plasmids. pMTElA contains Ad5 sequences (open bar) extending from a
HindIII linker inserted near the transcriptional start site (estimated at nt 493) to the viral PstI site at nt 1834. ElA sequences were joined to
a 1.4-kilobase fragment containing the promoter of the mouse metallothionein I gene (blackened bar). A BgllI site near the metallothionein
promoter was converted to a HindIll site for this purpose. pMTEBElA is similar to pMTElA except that the PstI site was converted to a
BamHI site. The plasmid vector for both constructs was pAT153 (thin line). 13S and 12S cDNA clones were isolated from an early Ad2 library
(15) by hybridization to a 32P-labeled Hpal E fragment probe (O to 4.3 map units). Positive clones were analyzed by restriction endonuclease
cleavage, and the region between the viral ClaI and XbaI sites was sequenced. pMT13S and pMTEB12S were constructed by exchanging
cDNA sequences (hatched bar) contained within an XmaI-XbaI fragment (13S) or a Clal-Xbal fragment (12S) with the corresponding genomic
sequences of pMTElA and pMTEB1A.
MATERIALS AND METHODS
Cells and plasmid DNAs. Cultures of primary baby rat
kidney (BRK) cells were prepared and transfected by the
DNA-calcium phosphate coprecipitation method as de-
scribed previously (45). Plasmids not described in the text
contained the following viral and cellular sequences: pT24,
the activated Ha-ras 1 gene isolated from human T24 bladder
carcinoma cells (17); pPyMT, a modified polyomavirus
genome which expresses only the middle T antigen protein
(55); pHrl and pHrA, adenovirus 5 (AdS) ElA sequences
contained in the BalI I fragment (0.7 to 5.7 map units) of Ad5
hrl and hr440 host range mutants, respectively (D. Solnick,
unpublished data); and dl343, AdS ElA sequences extending
between nucleotides (nt) 1 and 1834 but deleting nt 621 and
622 (P. Hearing, unpublished data).
Analysis of cellular RNA. RNA was isolated by the
guanidine thiocyanate method of Chirgwin et al. (11). Total
cellular RNA (20 jig) was analyzed as described previously
(61) after hybridization to 32P-labeled RNA probes (104 cpm;
Chrenkov) generated in vitro with SP6 polymerase. RNase-
protected fragments were fractionated on 5% polyacryl-
amide gels.
Hybridization, selection, and in vitro translation of ElA
RNAs. A 200-,ug sample of cytoplasmic RNA was hybridized
to pHEB4 DNA immobilized on nitrocellulose filters.
pHEB4 is a plasmid containing an Ad2 ElA DNA fragment
extending from the BalI site at base pair 267 to the HpaI site
at base pair 1569. RNA was eluted and translated with a
rabbit reticulocyte system as described by Lewis and
Mathews (35) and Solnick and Anderson (51). Polypeptides
synthesized in the presence of [35SJmethionine (New Eng-
land Nuclear Corp.) were fractionated on 15% sodium do-
decyl sulfate-polyacrylamide gels and detected by
fluorography.
Transient expression assays. Transfections were performed
by using a modification of the calcium phosphate coprecip-
itation technique (20, 59). HeLa cells at approximately 75%
confluence were fed with Dulbecco modified Eagle medium
containing 5% fetal calf serum approximately 4 h before
transfection. A 20-gig portion of DNA (5 gig of pKCAT23 [a
gift from N. C. Jones] plus 5 ,ug of ElA plasmid and 10 gig of
high-molecular-weight salmon sperm DNA) was suspended
in 250 ,ul of 2x HEPES-buffered saline (pH 7.05) containing
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NaCl, 16; KCI, 0.74; Na2HPO4, 0.25; and glucose, 2. An
equal volume of 0.25 M CaCI2 was added dropwise, and the
mixture was allowed to form a precipitate for 10 min at room
temperature. The precipitate was added to 6-cm plates
containing 2 ml of fresh medium; the plates were incubated
at room temperature for 20 min, and then the medium was
brought back up to 5 ml, and the plates were placed at 37°C.
Four hours later, the medium was removed, and the plates
were (i) covered for 1 min with 2 ml of fresh medium
containing 15% glycerol, (ii) washed with phosphate-
buffered saline, and (iii) fed with 5 ml of fresh medium. Cells
were harvested 36 to 48 h later and assayed for chloram-
phenicol acetyltransferase activity as described by Gorman
et al. (18) and modified by Weeks and Jones (57), except that
half of the lysate from a 6-cm plate was incubated with 0.1
mCi of [14C]chloramphenicol (approximately 40 mCi/mM;
New England Nuclear Corp., 48 RI of distilled water, and 1
,ul of 40 mM acetyl coenzyme A (Sigma Chemical Co.).
RESULTS
Construction of ElA cDNA genes. cDNAs spanning the
introns of the 12S and 13S RNAs were isolated from a cDNA
library constructed from RNA extracted from Ad2-infected
HeLa cells early in infection (15). In each case, the integrity
of the splice junctions (41) and protein-coding sequences was
confirmed by DNA sequence determination by using the
chain termination method (data not shown). ElA genes
which individually express only 12S and 13S RNAs and thus
separately express only the 243- and 289-amino acid proteins
were reconstructed from the appropriate cDNA segments
(Fig. 1). Since the 289-amino acid protein stimulates expres-
sion of the viral ElA promoter (4, 36), the cDNA genes were
placed under the transcriptional control of the mouse metal-
lothionein I promoter (12) to help ensure that the 13S and
12S cDNA genes would be expressed at similar levels.
No cDNAs spanning the intron of the 9S RNA were
obtained, probably because the 9S mRNA becomes abun-
dant only at late times after infection. Consequently, an ElA
gene was constructed in which the 9S intron had been
deleted (Fig. 2). Briefly, endonuclease AvaII cleaves the 12S
cDNA 18 nt proximal to the 9S donor splice site and 1 nt
distal to the 9S splice acceptor (57). Complementary syn-
thetic oligonucleotides with AvaIl cohesive ends were syn-
thesized which precisely deleted the intron for the 9S
mRNA, and an ElA gene colinear with the 9S transcript was
reconstructed (MTEB9S).
Figure 3 summarizes the transcription and translation
products encoded by the ElA cDNAs and by mutant
genomic ElA regions. pHrl and pHrA contain the ElA
region isolated from Ad5 hrl and hr440 host range mutant
viruses. The hrl mutation deletes 1 nt in the intron of the 12S
RNA, resulting in the synthesis of a truncated form of the
289-amino acid protein but having no effect on the 243-amino
acid protein (14, 44). hrA contains two base changes which
prevent splicing of the 12S mRNA, and consequently the
243-amino acid protein is not made. One of the base changes
introduces a termination codon in the reading frame of the
13S mRNA, resulting in a truncated polypeptide containing
140 amino acids derived from amino-terminal sequences
common to both ElA proteins (50). Finally, d1343 deletes nt
620 and 621 (Hearing, unpublished data). The sequence of
d1343 predicts that a frame shift in ElA coding sequences
results in the synthesis of a peptide containing 28 amino
acids.
Oncogene collaborations. To probe ElA transforming func-

















FIG. 2. Construction of ElA 9S cDNA expression plasmid. The
smaller Hindlll-XbaI fragment of pMTEB12S was digested with
Avall, which cut the 12S cDNA at nt 618 and at the 9S splice
acceptor site at nt 1224. The resulting HindIlI-AvaIl and AvaII-XbaI
fragments were purified and ligated to synthetic complementary
oligonucleotides which encompassed the sequence between nt 619
and the 9S splice donor site at nt 636 and formed overhanging Avail
cohesive ends when annealed. The resulting 9S cDNA was then
cloned into the HindIII-XbaI backbone of pMTEB12S to make
pMTEB9S.
(MT13S), 12S (MTEB12S), and 9S (MTEB9S) mRNAs, as
well as plasmids carrying mutant ElA regions, were
transfected into primary BRK cells alone or together with
plasmids containing either pmt or T24 Ha-ras genes.
Transfected cultures were monitored for periods of up to 8
weeks for the outgrowth of transformed foci or for clones of
cells with extended growth potential.
The results of several experiments are summarized in
Table 1. In short, all of the mutant ElA plasmids with the
exception of pd1343 and pMTEB9S collaborated with T24
Ha-ras to induce transformed foci. The ability of pHrA to
collaborate with T24 Ha-ras suggests that ElA functions
important in transformation are located in the amino-
terminal domain common to the 289- and 243-amino acid
proteins (Fig. 3). That the 12S and 13S cDNA plasmids were
VOL. 6, 1986




























FIG. 3. Adenovirus ElA transcription and translation products. Shown are schematic representations of Adenovirus ElA transcripts (I),
the reading frame which encodes the 289- and 243-amino acid ElA proteins ('/1), and alternative translational reading frames (111).
pMTEB9S encodes the ElA 9S mRNA and a 55-amino acid protein; pMTEB12S encodes the ElA 12S mRNA and a 243-amino acid protein;
pMT13S encodes the ElA 13S mRNA and a 289-amino acid protein; phrl transcripts are spliced to 12S and 13S mRNAs which encode the
243-amino acid protein and a truncated polypeptide containing 175 amino acids, of which 10 amino acids are out of frame; pHrA transcripts
are spliced to the 13S mRNA, which encodes a truncated polypeptide of 140 amino acids; d1343 synthesizes the 12S and 13S mRNAs and
encodes a truncated polypeptide containing 28 amino acids, of which 8 amino acids are out of frame.
similarly active is consistent with this notion and indicates
that the 289- and 243-amino acid proteins express similar
activities that are important in the transformation of primary
BRK cells. Focus assays after transfection by ElA plasmids
alone or together with T24 Ha-ras are shown in Fig. 4. ElA
plasmids which complemented T24 Ha-ras were generally
also able to collaborate with pmt (Table 1). However, pHrA
did not enable pmt to induce transformed foci of primary
BRK cells.
As transfected DNA sequences recombine efficiently, the
oncogene collaborations might result from sequences on the
ElA plasmids (such as an enhancer) which influence the
expression of cotransfected genes if brought to a contiguous
location by DNA transfection. However, d1343, which con-
tains the adenovirus ElA promoter, and MTEB9S, which
contains the metallothionein I promoter, failed to comple-
ment T24 Ha-ras. These results indicate that the collabora-
tive functions of ElA resulted from the expression of a
protein product and did not result from sequences present on
the ElA plasmids.
Cells transformed by ElA and either T24 Ha-ras or pmt
plasmids were trypsinized within cloning cylinders, trans-
ferred to cloning wells (2 cm2), and consequently expanded
to mass culture. DNA was extracted and analyzed by
Southern blot hybridization for the presence of sequences
homologous to the transfected DNAs. In all cases, the
transformed cell lines contained sequences related to the
transfected plasmids, and the pattern of hybridizing frag-
ments confirmed the clonal independence of each cell line
(data not shown).
Phase-contrast photomicrographs of BRK cells trans-
formed by ElA and T24 Ha-ras or pmt plasmids are shown
in Fig. 5. The morphologies of cells transformed by pHrA
and T24 Ha-ras were particularly distinctive. In particular,
the cells were epithelial in appearance, a fact which also
accounted for distinctive foci produced by pHrA and T24
Ha-ras (Fig. 4). In contrast, cells transformed by other ElA
plasmids and T24 Ha-ras were less adherent and more
refractile. Reasons for these differences are unknown.
Establishment functions of ElA. The primary explants of
BRK cells used in these studies had limited lifespans in
serum-containing media. Upon reaching confluence, the
cultures rapidly degenerated and became depleted of epithe-
lial cells as a result of cell death and conversion to
nonepithelial morphologies. Fibroblast overgrowth was also
limited so that after 4 weeks in culture, the cells formed
sparse monolayers with few cell-cell contacts. In vitro
establishment of BRK cells by pMTE1A, pMT13S,
pMTEB12S, and pHrl was easily demonstrated, since
transfecting these plasmids gave rise to morphologically
distinct, progressively growing colonies. By contrast, nei-
ther T24 Ha-ras nor pmt induced observable alterations in
cell growth or morphology.
Microscopic inspection of transfected cultures indicated
that the colonies induced by ElA plasmids alone arose
within 7 days of transfection. Moreover, colonies arose at
frequencies similar to those of the transformants generated
by cotransfection of ElA and pmt and only slightly less than
those with T24 Ha-ras (Table 1). These results suggest that
extended growth potential was a direct response to introduc-
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ing ElA genes and did not require secondary events within
the transfected cells.
BRK cells transfected wtih ElA or MT13S plasmids alone
have been established, cloned, and maintained with weekly
passaging for over 6 months (about 60 cell doublings) with-
out crisis. Initially, cells from growing colonies were trypsin-
ized within cloning cylinders and were plated in cloning
wells (2 cm2). However, with few exceptions, cells trans-
ferred in this manner failed to thrive. Subsequently estab-
lished cell populations were isolated as follows: 4 weeks
posttransfection, transfected cultures containing 5 to 6 col-
onies (representing 1,000 to 2,000 cells) were passaged onto
culture dishes of similar area. Many of the cells passaged in
this manner attached and continued to proliferate. After 4
weeks, the nearly confluent cultures were split 1:2. At this
point, the cells had undergone at least 20 doublings, and cells
were cloned by limiting dilution and expanded in mass
culture. A total of six clones derived from a single
transfected plate were analyzed for the presence of ElA
sequences by Southern blot hybridization. All contained
identical patterns of hybridizing bands (data not shown),
indicating that one of the initial colonies outgrew the others
as the uncloned cell population was passaged.
pHrl and pMTEB12S plasmids also induced the out-
growth of cells with extended growth potential. While cells
within these colonies grew quickly, passaging the cells, even
as mass populations, proved difficult. The cells plated with
TABLE 1. Transformation of primary BRK cells with cloned
viral and cellular genesa
No. of foci on 4 plates in the following
Gene(s) experiment:
1 2 3 4
None (carrier alone) 0 0 0 0
T24 Ha-ras 0 0 0 0
PyMT 0 0 0 0
MTE1A (18) (21) (14) (19)
MT13S b (8) (5)
MTEB12S (7) (10)




MTE1A plus T24 Ha-ras 57 91 41 68
MTE1A plus PyMT 9 65 9 11
MT13S plusT24 Ha-ras - 28 34
MT13S plus PyMT - 4 6
MTEB12S plus T24 Ha-ras - 25 22
MTEB12S plus PyMT 5 8
MTEB9S plus T24 Ha-ras 0 0
MTEB9S plus PyMT 0 0
hrl plus T24 Ha-ras 61 48
hrl plus PyMT 5 9
hrA plus T24 Ha-ras 32 58
hrA plus PyMT 0 0
d1343 plus T24 Ha-ras 0 0
" Plasmids containing viral and cellular genes were transfected by
coprecipitation with calcium phosphate. Aliquots (0.5 ml) of DNA-calcium
phosphate coprecipitates containing 500 ng of each plasmid and 10 ,ug of rat
carrier DNA were added to 60-mm cultures of primary BRK cells. Cells were
fixed with methanol-acetone (1:1) and stained 18 to 56 days posttransfection.
Cells transfected with pMTE1A, pMT13S, pMTEB12S, and pHrl did not
form dense foci (Fig. 4) but formed colonies of cells having extended growth
potential as compared to cells transfected with carrier DNA alone. The
number of colonies of this type are indicated in parentheses except when
pMTE1A, pMT13S, pMTEB12S, and pHrl were cotransfected with other
plasmids.
b-, Not done.
low efficiencies after trypsinization (on the order of 0.1 to
1%), and in general, only clumps of cells reattached. We
suspect that these difficulties were related to the striking
epithelial morphologies of the pMTEB12S- and pHrl-
transfected cells (Fig. 5) and not to an intrinsic lack of
growth potential. Pretreatment of culture vessels with
collagen, fibronectin, or poly-L-lysine failed to improve
plating efficiencies; however, plating efficiencies gradually
improved after repeated passaging. Cells established by hrl
and pMTEB12S have been maintained in culture for over 6
months. This corresponds to at least 40 doublings, although,
given the low plating efficiencies, this figure is certain to be
an underestimate.
Transfection of primary BRK cells with pHrA did not
generate morphologically distinct colonies of cells (Fig. 5);
thus, the ability of hrA to promote primary cell establish-
ment was more difficult to demonstrate. However, by pas-
saging transfected cultures, it was possible to isolate popu-
lations of established cells essentially as before, although an
additional passaging step was required. Thus, transfected
cultures were passaged 4 weeks posttransfection onto cul-
ture dishes of similar area. After 4 weeks, the cultures
contained two to five growing colonies, which were passaged
again onto culture dishes of similar area. After 3 weeks,
confluent cultures were split 1:2 and were subsequently
subcloned by limiting dilution. DNAs from six clones were
analyzed by Southern blot hybridization, and ElA se-
quences were present as single inserts of similar size in two
clones, suggesting that both were sibling clones (data not
shown).
Phase-contrast photomicrographs of BRK cells estab-
lished by pMTE1A, pMT13S, pMTEB12S, pHrl, and pHrA
are shown in Fig. 5. All exhibited properties expected of
nontransformed established cell lines. In particular, the cells
displayed high serum requirements for growth, grew to low
saturation densities, and failed to form tumors in syngeneic
rats after subcutaneous injection of 106 cells.
In repeated experiments in addition to those listed in Table
1, the T24 Ha-ras, pmt, MTEB9S, and ElA mutant dl343,
individually and in combinations, failed to induce observable
alterations in the growth or morphology of primary BRK
cells. Failure of the T24 Ha-ras gene to transform was
confirmed in attempts to detect cellular genes in DNA from
human tumor cells which might enable T24 Ha-ras to trans-
form primary BRK cells. In particular, DNA extracted from
six tumor cell lines when cotransfected with T24 Ha-ras gave
rise to four untransformed colonies on 600 dishes of primary
BRK cells. However, cells derived from these colonies
required months to establish and contained neither human
Alii repeat sequence DNA nor sequences related to the T24
Ha-ras plasmid, as judged by Southern blot analysis. One
assumes, therefore, that these clones represented rare, spon-
taneously established variants.
Transforming functions of EIA plasmids. The ability of
plasmids to facilitate establishment in vitro and to collabo-
rate with T24 Ha-ras or polyomavirus middle T in transfor-
mation is summarized in Table 2. Briefly, with the exception
of pHrA, all plasmids which individually facilitated estab-
lishment of primary BRK cells also collaborated with T24
Ha-ras and polyomavirus middle T in transformation. (pHrA
cooperated with T24 Ha-ras in transformation but not with
polyomavirus middle T). These results indicate that activi-
ties which enable T24 Ha-ras and polyomavirus middle T to
transform cultured primary BRK cells are tightly linked to
activities which facilitate in vitro establishment.
In other experiments, we assessed the ability of T24
VOL. 6, 1986














FIG. 4. Focus assay after transfection of BRK cells by ElA plasmids alone or together with T24 Ha-ras. Cells were transfected with
cloned genes, fixed, and stained as described in the legend to Table 1. Transfected cultures were stained after 8 weeks except those on plates
d, f, h, j, and 1, which were stained after 18 days. Plates: a, no plasmid (carrier alone); b, T24 Ha-ras; c, MTE1A; d, MTE1A plus T24 Ha-ras;
e, pHrA; f, pHrA plus T24 Ha-ras; g, pHrl; h, pHrl plus T24 Ha-ras; i, MT13S; j, MT13S plus T24 Ha-ras; k, MTEB12S; 1, MTEB12S plus
T24 Ha-ras; m, MTEB9S; n, MTEB9S plus T24 Ha-ras; o, d1343; p, dl343 plus T24 Ha-ras.
Ha-ras cotransformants to form progressively growing tu-
mors in 14-day-old syngeneic rats after subcutaneous injec-
tion of 106 cells (Table 2). However, no consistent pattern
emerged with regard to other transformation parameters,
namely, tumorigenicity of T24 Ha-ras cotransformants or
ability to collaborate with polyomavirus middle T. Thus,
pHrA failed to collaborate with polyomavirus middle T, but
hrA/T24 Ha-ras cotransformants were tumorigenic in
syngeneic rats. On the other hand, pHrl collaborated with
polyomavirus middle T, but hrl/T24 Ha-ras cotransformants
were not tumorigenic.
ElA gene expression and detection of ElA mutant tran-
scripts. RNA was extracted from cells transformed by T24
Ha-ras and MTE1A, MT13S, or MTEB12S. ElA related
transcripts were analyzed after hybridization to probes gen-
erated in vitro with SP6 polymerase. Cells transformed by
MTE1A and either T24 Ha-ras or polyomavirus middle T
expressed both 12S and 13S ElA mRNAs, whereas cells
transformed with ElA cDNA plasmids (pMT13S or
pMTEB12S) expressed only the appropriate ElA mRNA
(Fig. 6A).
In a similar analysis performed on cells transformed by
T24 Ha-ras and either hrA or hrl, SP6 probes generated
from wild-type Ad5 ElA (Fig. 6B) were used initially. As
HrA is unable to splice 12S RNA, we had expected frag-
ments of 299 and 117 nt derived from the 5' and 3' exons of
the 13S transcript to be protected. Instead, the AdS ElA SP6
probe protected fragments of approximately 165 and 117 nt
(Fig. 6B, lane 3), similar in size to fragments diagnostic of
the 12S transcript (Fig. 6B, lane 7). In addition, a 137-nt
fragment was generated. This result suggested that hybrids
formed between the wild-type Ad5 ElA probe and AdS hrA
13S RNA were cleaved internally near the 12S splice donor
due to mismatched base pairs resulting from the hrA lesion.
This possibility was confirmed by using an SP6 probe
generated from hrA ElA sequences. The hrA probe pro-
tected fragments diagnostic of 13S transcripts, confirming
that hrA/T24 transformants express only the 13S ElA (Fig.
6B, lane 5).
Likewise, hybrids formed between AdS hrl RNA and
wild-type Ad5 ElA probe were partially cleaved at the site of
the hrl lesion (Fig. 6B, lane 4). This was indicated by the
appearance of a protected fragment 241 nt in size derived
from cleavage of the 299-nt fragment. However, an SP6
probe generated from hrl sequences protected the expected
fragments characteristic of 13S and 12S transcripts (Fig. 6B,
lane 6).





















FIG. 5. Established and transformed BRK cell clones. Primary BRK cells were established by transfecting ElA plasmids alone or were
transformed by cotransfecting ElA and either T24 Ha-ras or polyomavirus middle T plasmids. (A) pMTElA (clone MT1A-1); (B) pMTElA
plus T24 Ha-ras (clone MTlAR-1); (C) pMTElA plus polyomavirus middle T (clone MTlAMT-1); (D) pMT13S (clone 13S-1); (E) MT13S plus
T24 Ha-ras (clone 13SR-2); (F) MT13S plus polyomavirus middle T (clone 13SMT-1); (G) MTEB12S (clone 12S-1); (H) MTEB12S plus T24
Ha-ras (clone 12SR-1); (I) MTEB12S plus polyomavirus middle T (clone 12S MTI); (J) pHrl (clone Hrl-1); K, pHrl plus T24 Ha-ras (clone
9-3-1); (L) pHrl plus polyomavirus middle T (clone Hrl MT-2); (M) pHrA (clone HrA-2); (N) pHrA plus T24 Ha-ras (clone 28-3-1). Clones
derived from transformed foci (panels B, C, E, F, H, I, K, L, and N) were photographed after approximately 30 cell doublings. Established
clones derived after transfection of ElA plasmids alone (panels A, D, G, J, and M) were photographed after subcloning from serially passaged
mass cultures (see the text) after an estimated 40 to 60 cell doublings. All photomicrographs were taken with a lOx objective. Prints were all
made at identical magnifications.
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TABLE 2. Transforming functions of ElA plasmids
Facilitation Collaboration Production of Collaboration
Plasmid of establish- with T24 tumorigenic with polyoma-
ras cotrans- virus middlement Ha-ras fratformants T
pMTElA + + + +
pMT13S + + + +
pMTEB12S + + + +
pMTEB9S - -
pHrl + + - +
pHrA + b + +
pd1343 - -
aPlasmids expressing wild-type and mutant adenovirus ElA transcription
units were introduced into BRK cells individually and together with plasmids
expressing the T24 Ha-ras and polyomavirus middle T antigen genes. The
ability (+) or inability (-) of ElA plasmids to facilitate establishment of
primary BRK cells and to collaborate with T24 Ha-ras and polyomavirus
middle T antigen to induce transformed foci is indicated. Transformants
generated after cotransfection of ElA plasmids and T24 Ha-ras were tested
for tumorigenicity in 14-day-old syngeneic rats after subcutaneous injection of
106 cells. Three transformed lines generated with each ElA plasmid were
injected into four animals each. All ElA-ras cotransformants (except hrl-ras
cotransformants) gave rise (within 4 weeks) to progressively growing tumors
in at least two of the injected animals, whereas none of the three hrl-ras-
transformed lines induced tumors after 12 weeks.
b Establishment activities of pHrA were low as compared with those of
other ElA plasmids.
constructed with Ad2 cDNA sequences inserted into AdS
ElA genes. Ad2 mRNA sequences are identical to swapped
Ad5 sequences except at nt 1287, 1297, and 1301. Cleavage
at these positions would generate multiple fragments derived
from the 117-nt fragment. It was not clear whether single
mismatched bases were cleaved under the conditions used in
this study. Nevertheless, the hrA mutation, consisting of
two adjacent base changes, and the hrl mutation, consisting
of a single-nucleotide deletion, were both detected by RNase
protection analysis. We are presently investigating whether
mutations resulting from single-base changes can be de-
tected by this method.
The presence of the expected viral mRNA in cells estab-
lished by ElA, ElA cDNAs, and pHrA was confirmed by
analysis of the in vitro translation products of ElA hybrid
selected RNA (Fig. 7). Hybrid-selected RNA isolated from
cells established by MT13S and MTEB12S generated trans-
lation products corresponding to the 289- and 243-amino acid
ElA proteins, respectively. RNA selected from cells estab-
lished by pHrA generated a smaller peptide band estimated
at 40 kilodaltons.
Gene activation by ElA products. The role of individual
ElA proteins regarding transcriptional activation of viral
early region promoters is not completely resolved. On one
hand, viruses expressing only the 13S ElA RNA replicate as
efficiently as do wild-type viruses in HeLa cells (25, 36, 60;
B. Moran, T. Grodzicker, R. J. Roberts, M. B. Mathews,
and B. Zerler, J. Virol., in press), indicating that the 289-
amino acid protein is sufficient for transcriptional activation.
Moreover, mutants defective in the 289-amino acid protein,
such as AdS hrl, are defective for transcriptional activation
(4). On the other hand, several mutants defective in the
289-amino acid protein, such as AdS inSOO (8) and AdS hr440
(hrA) (51) retain partial transcription-activating functions. In
addition, conflicting results have been reported concerning
trans activation of early region promoters by cotransfected
ElA plasmids (34, 53).
In view of this somewhat contradictory literature, tran-
scriptional activation by ElA plasmids was assessed by a
transient assay system (58). This assay exploits the fact that
the bacterial chloramphenicol acetyltransferase gene under
transcriptional control of the adenovirus E3 promoter de-
pends on ElA for efficient expression.
Only those plasmids which encoded the 289-amino acid
ElA protein stimulated expression of E3CAT (Fig. 8; Table
3). Thus, pMTEB12S, pMTEB9S, pHrl, and pHrA failed to
stimulate E3CAT expression. Similar results were also ob-
tained with plasmids containing ElA, ElA13S, ElA12S, and
E1A9S genes expressed from the viral ElA promoter
(Moran et al. submitted). Moreover, we have reconstructed
mutant adenoviruses which separately express ElA tran-
scripts colinear with the 13S, 12S, and 9S cDNAs, and only
the 13S virus exhibited any ElA transcription-activating
functions (Moran et al., J. Virol., in press).
Together, the results of these experiments support previ-
ously published studies that the 289-amino acid protein is
responsible for most, if not all, ElA transcription-activating
functions. Since pMTEB12S, pHrl, and HrA collaborate
with T24 Ha-ras and facilitate in vitro establishment, we
conclude that neither of these activities is linked to ElA
functions required for efficient transcriptional activation of
viral early region promoters.
DISCUSSION
Neither T24 Ha-ras nor pmt induced observable alter-
ations in the growth or morphology of primary BRK cells.
By contrast, both genes induced phenotypes associated with
oncogenic transformation when cotransfected with ElA
plasmids capable of facilitating in vitro establishment. Thus,
ElA activities which enable ras and pmt genes to transform
primary BRK cells appear to be linked to ElA functions
which facilitate in vitro establishment. Furthermore, both
ElA activities were expressed by sequences encoding a
protein containing 140 amino acids, derived from the amino-
terminal domain shared by the ElA 289- and 243-amino acid
proteins. These results provide further evidence that
oncogenic transformation can require complementing activ-
ities which separately enable cultured cells to escape senes-
cence and acquire tumorigenic phenotypes.
The biochemical basis for the establishment and trans-
forming steps and how these collaborate is presently un-
known. While ElA increases the proliferative potential of
primary BRK cells and facilitates in vitro establishment,
serum growth factors, T24 Ha-ras, and pmt fail to alter
cellular commitments towards growth arrest and senes-
cence. Indeed, by facilitating establishment, ElA appears to
enable BRK cells to respond to activities of serum growth
factors and ras and pmt oncogenes.
Several observations suggest that in vitro establishment is
not an obligatory consequence of extended proliferative
potential. (i) Cells from progressively growing colonies in-
duced by ElA initially failed to grow when plated at low cell
densities. (ii) Cells from individual clones rapidly overgrew
mass cultures established from several ElA-induced colo-
nies. (iii) The plating efficiencies of cells established by pHrl
and 12S cDNA plasmids improved gradually as a result of
successive passages. Thus, in vitro establishment and the
ability to grow indefinitely in serum-containing media prob-
ably require adapative changes in addition to extended
growth potential induced by ElA.
Transfected pHrA did not clearly induce morphologically
altered colonies ofBRK cells. Therefore, the ability ofpHrA
to alter the growth potential of BRK cells was more difficult
to establish as compared with other ElA plasmids. How-
ever, since spontaneous establishment and DNA uptake
after transfection are both rare events, it seems unlikely that
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FIG. 6. ElA transcripts in transformed BRK clones. RNA from BRK cell clones was annealed to 32P-labeled RNA probes generated in
vitro by SP6 polymerase. Fragments resistant to RNase digestion were analyzed by polyacrylamide gel electrophoresis and autoradiography.
RNA probes complementary to ElA transcripts were expected to protect fragments of 299 and 117 nt and 161 and 117 nt derived from 13S
and 12S transcripts, respectively. Sequences corresponding to SP6 probes and also fragments expected to be protected by RNA from ElA
mutant and cDNA genes are indicated schematically. (A) RNA isolated from the following BRK cell clones was annealed to AdS SP6 probes
and analyzed as described above: clone MTlA1 (lane 1), established by pMTE1A; clone MTlAR-1 (lane 2); clones MT1AR-2 (lane 3) and
MT1AR-3 (lane 4), transformed by pMTElA and pT24; clones MTlAMT-1 (lane 5) and MT1AMT-2 (lane 6), transformed by pMTElA and
pPyMT; 12SR-1 (lane 7), 12SR-2 (lane 8), and 12SR-3 (lane 9), transformed by pMTEB12S and pT24; 12S MT-1 (lane 10) and 12S MT-2 (lane
11), transformed by pMTEB12S and pPyMT; 13SR-1 (lane 12), 13SR-2 (lane 13), 13SR-3 (lane 14), and 13SR-4 (lane 15), transformed by
pMT13S and pT24; 13SMT-1 (lane 16), transformed by pMT13S and pPyMT. Lane 17, Size markers derived from end-labeled HinfI-digested
pAT153 DNA; lane 18, AdS SP6 probe. (B) RNA extracted from BRK cell lines was annealed to the indicated SP6 probes and analyzed as
described above: primary BRK cell, Ad5 probe (lane 1); (2) MTlAMT-1 transformed by pMTElA and pPyMT, AdS probe (lane 2); 9-3-1
transformed by pHrl and pT24, AdS probe (lane 3); 28-3-1 transformed by pHrA and pT24, AdS probe (lane 4); 9-3-1, Ad5 hrl probe (lane
5); 28-3-1, Ad5 hrA probe (lane 6); 12SR-1 transformed by pMTEB12S and pT24, AdS probe (lane 7); 13SR-3 transformed by pMT13S and
pT24, AdS probe (lane 8). Lane 9, Size markers derived from end-labeled, HinfI-digested pAT153 DNA.
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FIG. 7. In vitro translation of ElA mRNAs isolated from E1A-
established BRK cell lines. Cytoplasmic RNA (200 ,ug) was hybrid-
ized to an ElA plasmid (pHEB4) immobilized on nitrocellulose
filters. Eluted RNA was translated in vitro in the presence of
[35S]methionine, and the products were fractionated on a 15%
sodium dodecyl sulfate-polyacrylamide gel. RNA was isolated from
the following cells: primary BRK cells (lane 1), MTEB12S-
established BRK cells (lane 2), MT13S-established BRK cells (lane
3), HrA-established BRK cells (lane 4), 14-C labelled markers (lane
5), and Ad2-infected HeLa cells (lane 6).
established cells would contain and express transfected
genes unless these participated in establishment. Therefore,
pHrA appears to facilitate establishment at a low, but
detectable, frequency.
CH *
pHrA also failed to complement pmt in primary cell
transformation. In this respect, hrA resembles pit, since plt
also fails to collaborate with pmt but facilitates in vitro
establishment and collaborates with ras oncogenes to trans-
form rat embryo fibroblasts (33, 42, 43). These results
indicate that certain combinations of plasmids which sepa-
rately express establishment and transforming functions do
not cooperate to transform primary cells.
Studies with AdS hr440 (hrA) and hrl and viruses which
individually express only the 243- and 289-amino acid pro-
teins have shown that all are defective with regard to
transformation of cultured primary cells (2, 19, 22, 23, 25, 37,
51, 60; Moran et al., in press). However, viral transforma-
tion may be influenced by transcriptional effects such as
autoregulation of ElA or activation of E1B as well as viral
cytotoxicity in semipermissive rodent cells. These consider-
ations greatly complicate understanding of the individual
roles of the 243- and 289-amino acid proteins in virus-
induced cell transformation. The present study indicates that
the ElA regions of all of these viruses retain functions
required to facilitate in vitro establishment and to collabo-
rate with oncogenes in primary cell transformation.
While the biochemical functions of ElA proteins are
unknown, ElA expresses at least two functions required for
virus replication. Thus, ElA activates viral early gene tran-
scription and greatly stimulates virus replication in quiescent
cells. These two functions may be mediated by separate
biochemical activities, since the 289-amino acid protein
expresses most, if not all, of the ElA transcriptional activi-
ties, whereas the 243-amino acid protein stimulates virus
replication in quiescent cells to a greater extent than does the
289-amino acid protein (37). In addition, both ElA proteins
can influence expression of certain nonviral genes, either
resident within the genome or carried on transfected plas-
mids; however, the 243-amino acid protein is active only
*
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FIG. 8. Transcriptional activation by ElA plasmids. A 5-,ug sample of the indicated plasmid DNA, along with 5 ,ug of pKCAT23 and 10
,ug of carrier DNA, was transfected into HeLa cells by calcium phosphate coprecipitation. After 48 h, cells were harvested, and extracts were
assayed for chloramphenicol acetyltransferase activity. Lanes: 1, pKCAT23 alone; 2 and 3, MTEB9S plus pKCAT23; 4 and 5, pMTEB12S
plus pKCAT23; 6 and 7, pMT13S plus pKCAT23; 8 and 9, pMTElA plus pKCAT23; 10 and 11, pHrA plus pKCAT23; 12 and 13, pHrl plus
pKCAT23. Acetylated (AC) and unacetylated (CH) forms of chloramphenicol are indicated.
AC
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TABLE 3. Transcriptional activation by ElA plasmids
Plasmid % Chloramphenicolacetylated per ha
pMTElA ..................................... 69 11
pMT13S ..................................... 82 ± 3
pMTEB12S ..................................... 9.1 ± 0.1
pMTEB9S ..................................... 6.6 t 1.2
pHrl..................................... 2.2 ± 0.8
pHrA ..................................... 11.3 ± 2.6
pBR322 ..................................... 7.4 t 0.8
a Plasmid DNAs were cotransfected with pKCAT23 which contains the
bacterial chloramphenicol acetyltransferase gene expressed from the adeno-
virus E3 promoter. Acetylation of chloramphenicol was monitored after
thin-layer chromatography and is expressed as percent chloramphenicol
acetylated per hour. Mean and standard deviation of at least two experiments
are given.
with a subset of genes affected by the 289-amino acid protein
(34, 47, 53, 56). Finally, both ElA proteins stimulate cellular
DNA synthesis during lytic infection (3, 52); however, only
the 289-amino acid protein induces cell cycle progression (3).
The relationship of these biological activities to transfor-
mation is presently unknown, but the activities implicate
transcription and DNA replication as targets of ElA func-
tions. Transcriptional effects of ElA are particularly inter-
esting since associations between transcriptional activation
and transformation have been noted for proteins other than
ElA (6, 10, 31, 32, 49). Unfortunately, experimental evi-
dence linking transcriptional effects and transformation is
inconclusive. On one hand, the present study indicates that
ElA functions which facilitate establishment are separate
from activities of the 289-amino acid protein which activate
transcription of the viral early region genes. On the other
hand, transcription and transformation phenotypes could
result from different thresholds of a single activity rather
than from separate biochemical activities. Moreover, viral
and cellular genes may differ in their responses to ElA. In
either event, since ElA activities which induce cultured
primary cells to proliferate must also alter cellular gene
expression, distinguishing cause and effect will be a difficult
undertaking.
Understanding how ElA transcriptional effect influences
transformation is further complicated by the fact that many
transcriptional phenotypes associated with ElA appear to be
indirect. The wide variety of transcriptional phenotypes
associated with ElA suggests that ElA can influence tran-
scription at many different levels. Kinetics of transcriptional
activation suggests that ElA acts in collaboration with other
cellular proteins to alter transcription units in cis (16).
Moreover, ElA proteins may not interact directly with
promoter elements, since sequences necessary for gene
expression in the presence of ElA vary for different promot-
ers (21, 27, 54). Finally, a variety of factors, including
inhibitors of protein synthesis (38, 48), cell differentiation
(26), and tumor promoters (9), all influence transcriptional
phenotypes associated with ElA.
Several investigators (36, 52) have proposed that ElA
activities which stimulate adenovirus replication in quies-
cent cells participate directly in primary cell transformation.
If this hypothesis is correct, quantitative rather than quali-
tative differences would appear to distinguish the 243- and
289-amino-acid proteins with regard to activities necessary
for the efficient infection of quiescent cells, since the 289-
and 243-amino acid proteins express similar transforming
functions. While it is not clear how ElA transforming
activities participate in virus replication, these activities
presumably help create or maintain cellular environments
permissive for viral DNA replication. It is interesting that
phenotypes induced by ElA are also induced by cellular
genes, including certain oncogenes activated in tumor cells
(13, 28, 33, 40). ElA may therefore activate or express
activities similar to these oncogene proteins.
While the biochemical functions of the ElA proteins are
unknown, ElA alters the ability of BRK cells to respond to
activities of T24 Ha-ras p21 and pmt as well as to activities
induced by serum growth factors. The requirement for
collaborations between oncogenes to transform primary
BRK cells has allowed the transforming functions of ElA
proteins to be more accurately defined. This system, as well
as others in which cellular responses to serum growth factors
and to certain oncogene proteins are conditional on
coexpression of genes such as ElA, may allow complement-
ing biochemical activities involved in oncogenic transforma-
tion to be identified. This will assist efforts to understand the
biochemical functions of ElA and mechanisms which regu-
late how cells synthesize and respond to signals involved in
cellular growth control.
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